Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
News Release Digital Asset Direct

News Release

Xeris Biopharma enters research collaboration with Regeneron Pharmaceuticals to advance XeriJect

Xeris Biopharma Holdings

Xeris Biopharma chairman and CEO Paul Edick joins Proactive's Natalie Stoberman to share details behind its research evaluation collaboration with Regeneron Pharmaceuticals for further XeriJect development. Edick says the agreement will see Xeris using its proprietary drug-formulation platform, XeriJect, to develop ultra-highly concentrated, ready-to-use, small volume subcutaneous injections of two undisclosed monoclonal antibodies developed by Regeneron. Xeris will receive an upfront payment and potential milestone payments for preclinical achievements. Regeneron will have an option to commercially license the Xeris technology for such molecules and nominate additional molecules for reformulation and potential commercialization. Contact Details Proactive Investors +1 347-449-0879 na-editorial@proactiveinvestors.com

April 05, 2023 01:18 PM Eastern Daylight Time

Video

News Release

HealthLynked discusses year-end financials and MedOfficeDirect prospects in development

HealthLynked

HealthLynked chairman and CEO Dr Michael Dent and chief financial officer George O'Leary join Proactive's Natalie Stoberman to share highlights from the company's fourth-quarter and full-year 2022 financial results. HealthLynked reported revenue of $5.86 million, a 10% decrease compared to $6.50 million in 2021. Dent says the decline is primarily attributed to decreases in patient service revenue at the Naples Women’s Center and Bridging the Gap facilities, as well as lower product revenue from MedOfficeDirect. However, the company has reported that the decrease was partially offset by revenue increases at its Naples Center for Functional Medicine facility and revenue from the newly-acquired Aesthetics Enhancements Unlimited practice. Contact Details Proactive Investors +1 347-449-0879 na-editorial@proactiveinvestors.com

April 05, 2023 01:13 PM Eastern Daylight Time

Video

Algernon NeuroScience reports successful second cohort dosing in DMT clinical study

Algernon Pharmaceuticals Inc.

Algernon Pharmaceuticals CEO Christopher Moreau joined Steve Darling from Proactive to share news the company’s subsidiary Algernon Neuroscience has completed dosing of the second cohort in the Phase 1 clinical study of DMT. Moreau tells Proactive the study is to identify the safety and tolerability of DMT when administered as an intravenous bolus followed by a prolonged infusion of 6 hours which has never been studied clinically. Contact Details Proactive Investors +1 604-688-8158 na-editorial@proactiveinvestors.com

April 05, 2023 01:03 PM Eastern Daylight Time

Video

News Release

BioHarvest Sciences announces launch of “Real Stories” media campaign for VINIA red grape supplement

BioHarvest Sciences Inc.

BioHarvest Sciences CEO Ilan Sobel joined Steve Darling from Proactive to share news the company will be launching a major media campaign to support its flagship supplement VINIA in the United States. Sobel tells Proactive the campaign will use real VINIA users telling their ‘Real Stories” on television and social media. The science behind the product will also be highlighted. BioHarvest has set its 2023 guidance with plans to increase global VINIA sales to over US$17 million. Contact Details Proactive Investors +1 604-688-8158 na-editorial@proactiveinvestors.com

April 05, 2023 12:25 PM Eastern Daylight Time

Video

Software Effective Solutions "MEDCANA" (OTC: SFWJ) Provides Corporate Update for Shareholders

Software Effective Solutions Corp.

McapMediaWire -- Software Effective Solutions, (OTC: SFWJ ) (“The Company”, “SFWJ”) dba MedCana is a global holding company focused on acquiring and developing companies in the cannabis industry with initial focus in Central and South America. In late 2021, Software Effective Solutions Corp. dba MedCana acquired five companies with licenses to produce, process, and export cannabis with and without T.H.C. The purchased companies have a combined total area of 105 Acres (42.84 Hectares). MedCana has also secured the option to expand operations to an additional 177 Acres (72 Hectares) as needed. The primary area of operation is outside of Marinilla, a small town approximately one hour away from Medellin in the department of Antioquia, Colombia. Initial design as well as all environmental, geological, and hydrological have been completed and the project will be ready to break ground in June of 2023. In September 2022, MedCana also acquired Tokan Corp’s assets, a software company, with the focus of creating an ERP platform for the cannabis industry to track the seed to patient process. In October of 2022, MedCana acquired Eko2O S.A.S. a company focused on design and distribution of greenhouses and advanced irrigation platforms. The track record, experience, and industry knowledge that CEO Juan Ricardo Velez brings has set the company up for explosive growth in the region while also dramatically decreasing costs for MedCana’s subsidiaries in the region. SFWJ CEO Gabriel Diaz states, "We are extremely pleased with the progress we've made in the past several months. We look forward to updating shareholders, and are committed to doing everything possible to increase shareholder value." ABOUT SFWJ: Software Effective Solutions/MedCana is a global infrastructure and holding company in the cannabis industry. Currently, MedCana has five companies focused on pharmaceutical cannabis production, one software company focused on managing processes for plant-to-patient operations. The recent acquisition an irrigation and greenhouse technology company has rounded out MedCana’s portfolio of companies. MedCana's initial focus is on developing clients and companies in Latin America with an initial focus in Colombia and partnerships with laboratories, research facilities, and hospitals throughout the world. SAFE HARBOR STATEMENT This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made. Contact: Jose Gabriel Diaz, CEO www.medcana.net info@medcana.co Contact Details MedCana info@medcana.co Company Website https://www.medcana.net/

April 05, 2023 09:00 AM Eastern Daylight Time

Ultrack Enters Acquisition Agreement with Successful Medical and Wellness Company

Ultrack Systems, Inc.

McapMediaWire --Ultrack Systems Inc. (OTC: MJLB ), a total fleet-management GPS tracking and monitoring solution provider, is pleased to announce that Ultrack has entered into a formal contractual agreement with Supreme Products to both acquire and market their "Pet Tracker" product which is a wearable GPS device for pets. Notably, Carl Lamonte from Supreme Products will join Ultrack as an Officer of Brand Development Officer Earlier this year Ultrack noted in a release that the Company is actively seeking joint-venture relationships and/or acquisitions within recession proof sectors. Today's announcement is the initial fulfillment of that goal with more planned to come. With years of experience, resources, and relationships within the GPS industry, it makes sense for Ultrack to expand to the developing vertical market of pet tracking hardware and software. Currently, the global pet market is worth roughly $261 billion with the sub "pet care" market coming in at around $79 billion as of 2021. Current forecasters project that the U.S. pet market alone is projected to grow to $325 billion by 2028 with a projected sustained growth of pet ownership up to 14% by 2030. (Source: https://www.hepper.com/pet-industry-statistics-us / ) Ultrack CEO Michael Marsbergen commented: “Pets are big business and Millennials and Gen Z are leading the way for the foreseeable future. We believe that pet ownership and pet care is a recession-proof industry because people are simply not going to give up the things that they truly love, no matter how hard the economy gets hit. I'm delighted that Mr. Carl Lamonte will be joining Ultrack and helping the Company to establish sure footing as a new face and voice for our “Pet Tracker” product." Some of the ways the Company intends to provide a superior device include potential features like: 1. Health monitoring: Monitor a pet's health by tracking their activity levels, heart rate, and other biometric data. This information could be shared with veterinarians or pet owners to identify potential health problems early on. 2. Behavior modification: Modify a pet's behavior by providing real-time feedback on their location and activity level. For example, a device could be set up to alert a pet owner if their dog has strayed too far from home, or if their cat is spending too much time in a certain area. 3. Predictive analytics: Collect data on a pet's behavior and use machine learning algorithms to predict future behavior. This could help pet owners anticipate potential problems and take preventive action. 4. Social media integration: Integration with social media platforms, allowing pet owners to share their pet's location and activity level with friends and family. This could create a community of pet owners who share information and support each other. 5. Virtual fences: Create virtual fences around a pet's home or yard, alerting the pet owner if their pet strays beyond a certain boundary. This could be especially useful for pet owners who live in areas with high levels of traffic or other hazards. Ultrack and Supreme Products are planning a full-orbed marketing plan through multiple strategies including: As technology and AI evolves, the Company will seek for new ways to add more benefits to its line of pet care products. Investors can anticipate updates moving forward regarding details of the development and deployment of the new "Pet Tracker" product. Furthermore, the details of the contract with Supreme Products involves a marketing partnership to bring appropriate exposure to the new Pet Tracker product. These initiatives include but are not limited to: 1. Social media advertising: Social media platforms such as Facebook and Instagram offer targeted advertising options that allow businesses to reach pet owners directly, especially young pet owners. 2. Influencer marketing: Partnering with influencers in the pet industry can be an effective way to reach a wider audience. 3. Pet store partnerships: Starting with pet stores in Canada and established relationship, the Company believes this strategy will be well-received and well-rewarded. 4. Trade shows and events: The Company is looking ahead to three of the largest North American pet-focused trade shows in which to have a meaningful presence. The Company invites current and future shareholders to check back regularly at our website http://ultrack.ca, Facebook page: https://www.facebook.com/UltrackSolutions and Twitter page: https://twitter.com/ultracki About MJLB: Located in Concord, Ontario, Ultrack Systems Inc., ( www.ultrack.ca ) is a publicly traded company listed on the OTCMARKETS under the MJLB trading symbol. Ultrack Systems Inc., is a provider of GPS tracking solutions. We develop, implement, and distribute electronic monitoring and tracking systems for companies in leasing, transportation, construction, disposal, and many other services driven industries. Our platform includes live tracking, reports, and alerts on a web-based platform. Our mission is to provide the best fleet tracking, reporting systems and our commitment to service. The Company plans to launch a new ELD product in 2023 in partnership with major corporations that will take the trucking industry by storm. Safe Harbor Statement: This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this Press Release, including such forward-looking statements. Michael Stephen Marsbergen Ultrack Sytems Inc. +1 800-893-9506 sales@ultrack.ca Visit us on social media: Facebook Twitter Contact Details Ultrack Sytems Inc. sales@ultrack.ca Company Website http://ultrack.ca/

April 04, 2023 09:00 AM Eastern Daylight Time

TransGlobal Assets Inc. (OTC: TMSH) Acquires Industry-Heavyweight, Better Health Sciences Inc.

TransGlobal Assets, Inc.

McapMediaWire -- TransGlobal Assets Inc. (OTC: TMSH ) is pleased to announce that, pursuant to an Acquisition and Merger Agreement, it has acquired Better Health Sciences, Inc. Better Health Sciences Inc., is a pioneer in transforming the health and wellness industries through cutting-edge products and services. Our products and services are focused on being at the forefront of the health and wellness sectors, developing technologies and solutions that are driving industry growth and transforming lives. Led by a team of seasoned experts with deep experience in the healthcare and technology sectors, we are dedicated to creating innovative products and services that meet the evolving needs of consumers and healthcare providers alike. Attracting the attention of other industry leaders that recognize the next evolutionary steps in health and wellness has led to the acquisition, unification and strategic partnerships under the Better Health Sciences Inc., banner. Our portfolio includes a range of products and services, from telemedicine platforms to wellness retreats and natural health remedies. Our solutions are designed to be user-friendly, affordable, and accessible to all, and are built on the latest advances in science and technology. At Better Health Sciences, Inc., we are committed to staying ahead of the curve, anticipating trends, and driving innovation in the health and wellness industries. We are constantly exploring new ideas, building strategic partnerships, and collaborating with experts to push the boundaries of what's possible. Currently Better Health Sciences, Inc., has a customer base in excess of 5000 patients, assets in excess of 2.5 million and revenues exceeding $200,000. Our vision is to rapidly grow the company to over 5 million in assets with strategic acquisitions. Pursuant to the agreement, Better Health Sciences, Inc., will be the sole operating subsidiary of TMSH and all current assets on TMSH will be divested. Updates to the corporate website and OTC Markets will be forthcoming over the next several weeks. Furthermore, Ilya Strashun is appointed as the Sole Director and officer of the corporation with the contemporaneous resignation of Curtis Philpot. Mr. Strashun is an accomplished entrepreneur with a deep expertise in technology, marketing, and cannabis sectors. He began his career in advertising, leveraging his degree in Technology and Marketing to design and run award-winning multi-million dollar campaigns in both the NGO and for-profit sectors. After a decade in advertising, Ilya decided to pursue the entrepreneurial path, founding start-ups in the tech and services sectors. His passion for innovation and cutting-edge technologies led him to enter the legal cannabis sector in 2015, where he quickly made a name for himself as a co-founder of Cannascribe, one of Canada's first and longest operating cannabis prescription clinics. In addition to Cannascribe, Ilya has been involved with a cannabis formulations company that has created numerous leading tincture and topical formulations. Ilya has combined his expertise in growing, extracting techniques, and new technologies to help elevate the quality of products and knowledge that the company brings to the sector. Most recently Ilya has brought his knowledge and experience of the human cannabis sector and combined it with his passion for pets which focuses on product development in the pet health and wellness sector. Throughout his career, Ilya has demonstrated an unwavering commitment to innovation and excellence, pushing the boundaries of what's possible in the advertising, technology, and cannabis sectors. His leadership, creativity, and expertise have helped drive the growth and success of numerous ventures, making him a sought after team player and captain. Ilya Strashun, CEO of TransGlobal Assets Inc., states, “I look forward to building shareholder value through established strategic relationships. With a rapidly growing customer base and a track record of success, we are poised for even greater growth and expansion in the years ahead. We are a dominant force in the cannabis industry and we invite investors to join us on this exciting journey together towards a healthier, happier future as we expand into all facets of health and wellness.” Please visit our website https://www.transglobalassets.com/ for more information about TMSH. Legal Notice Regarding Forward-Looking Statements: This press release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and section 21E of the Securities Exchange Act of 1934 and is subject to the safe harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and jut uncertainties. That includes the possibility that the business outlined in this press release cannot be concluded for some reason. That could be as a result of technical, installation, permitting or other problems that were not anticipated. Such forward-looking statements involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of TransGlobal Assets, Inc. to be materially different from the statements made herein. Except for any obligation under the U.S. federal securities laws, TransGlobal Assets, Inc. undertakes no obligation to publicly update any forward-looking statement as a result of new information, future events or otherwise. Contact: TransGlobal Assets Inc. (OTC: TMSH) Phone: (734) 383-4770 Email: info@TransGlobalAssets.net Twitter: https://twitter.com/TMSH_OTC Facebook: https://www.facebook.com/TMSHotc/ Contact Details TransGlobal Assets Inc. info@TransGlobalAssets.net

April 04, 2023 09:00 AM Eastern Daylight Time

Ellipses Pharma has "quite a number" of promising cancer treatments in the pipeline

Ellipses Pharma

Ellipses Pharma founder and chairman Professor Sir Christopher Evans speaks to Proactive about his work at the cancer-focused international drug development company that he founded back in 2015. He reveals more about how the company operates and what it is he thinks makes Ellipses Pharma unique among its peers, before going on to highlight that there are "quite a number" of promising cancer treatments in the pipeline. Contact Details Proactive UK Ltd Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

April 04, 2023 03:59 AM Eastern Daylight Time

Video

AMERICAN DIVERSIFIED HOLDINGS CORPORATION (OTC: ADHC) ISSUES CORPORATE UPDATE

American Diversified Holdings Corp.

McapMediaWire -- American Diversified Holdings Corporation (OTC: ADHC ) announced today a corporate update regarding recent developments with the company. HIGHLIGHTS *Cancellation of 330,000,000 shares scheduled for Mid-April 2023 *New investor relations portal http://www.adhcinvestor.com unveiled today *New domain unveiled http://www.UniversalWellnessShop.com for all ecommerce *Strategic partnerships and acquisitions soon to be announced * ROLLS CHOICE™ adhesive pen being sold on amazon.com SHARE CANCELLATION ADHC has filed suit in The Eight Judicial Circuit Court, Clark County, Nevada, Case Number A-21-843-670, seeking the cancellation of 330,000,000 (330 MM) shares of common stock. On January 6, 2023, the court granted the motion for default. It is anticipated the court will be issuing the formal order soon on a scheduled hearing date on April 17th, 2023. Granting the default judgment is the final legal step before all litigation is resolved. Currently, ADHC capitalization structure is as follows: Shares Outstanding: 1.1 billion Shares Restricted: 600 million Shares in the Float: 504 million In additional developments, ADHC identified a new management team to lead a new business direction. It is anticipated that the new team will formally take over in conjunction with the culmination of the Nevada litigation. The new team has been targeting new acquisition candidates, major corporate alliances, new executive personnel and advisory board and identifying new business opportunities for the company. Cannabidiol (CBD) Market Size Worth USD 59.3 Billion by 2030 at 18.2% CAGR – Report by Market Research Future (MRFR) American Diversified Holdings Corporation operates two e-commerce sites focused on the emerging technologies: http://www.UniversalWellnessShop.com and www.RollsChoiceAdhesives.com. The business model includes selling products to consumers, driving traffic to partner sites, generating ad revenue and creating partnership opportunities for other wellness companies. 1. UNIVERSAL WELLNESS is a wellness and lifestyle ecommerce site focused upon providing innovative products, news and the latest health care developments for consumers nationwide. 2. ROLLS CHOICE™ is a Southern California-based manufacturer, distributor, and e-commerce company selling an all-natural Adhesive Glue and application device sold off AMAZON.com and through its own website. The Pens come in 1 ml, 2 ml and 100 pen packs. ROLLS CHOICE™ has significant brand awareness in the cannabis industry and boasts over 80,000 followers on Twitter and Instagram. Recently over 12,000 adhesive pens have been manufactured and sold. The adhesive is made of Food Grade Premium ingredients. ROLLS CHOICE™ Adhesive Pen is Flavorless, Colorless, Tasteless and Stainless. It is used to seal cannabis and tobacco rolled products including blunts, joints, cigars and hand rolled cigarettes in a sterile manner allowing for long lasting adhesive qualities. The proprietary brush tip pen is recommended for precision. RC sells direct to smoke shops, dispensaries and direct to consumers through its e-commerce site. Through the companies multi year history sales over 12,000 adhesive pens and been manufactured and sold by Rolls Choice. see (USPTO ROLLS CHOICE 97278083). ROLLS CHOICE™ has over 80,000 social media followers which will be introduced to ADHC social media platforms on Twitter, Instagram, Facebook, and TikTok. This relationship will establish a very strong presence providing brand awareness to potential customers and shareholders as the Universal Wellness/Rolls Choice business relationship develops and revenues grow. Website: www.RollsChoiceAdhesives.com. Email: rollschoicerepresentative619@gmail.com Twitter: https://www.twitter.com/rollschoice Instagram: https://www.instagram/rollschoicadhesivepen In addition to the adhesive pen, RC has numerous other cannabis related products being developed that will be introduced as a result of this Acquisition agreement. Shareholders, customers, and other interested parties can find product offerings by searching AMAZON under these UPC codes: B0B1BTNW4Q and B0B2R3D2TS or clicking this link: https://a.co/d/3ONJjGy Amazon.com: Rolls Choice™ Adhesive Pen (25, 1ml) Amazon.com: Adhesive 2ml (16 pens) ROLLS CHOICE™ has a pending trademark with the USPTO under the application number 972978083. Investor Contact: Ernest Remo Chairman/CEO EMAIL: ernestremo@san.rr.com Tel: 858-259-4534 TWITTER: @ADHCManagement. This Twitter page is the only official Twitter page for ADHC. Information contained herein includes forward-looking statements. These statements relate to future events or future financial performance, involving known and unknown risks and uncertainties that may cause our actual results to be materially different from the performance or achievements expressed. You should not place undue reliance on these statements since they involve known and unknown risks, in some cases, beyond our control. Contact Details Ernest Remo +1 858-259-4534 ernestremo@san.rr.com

April 03, 2023 06:30 AM Eastern Daylight Time

Image

1 ... 115 116 117 118 119 ... 248